|
1
|
Banerjee PS, Hart GW and Cho JW: Chemical
approaches to study O-GlcNAcylation. Chem Soc Rev. 42:4345–4357.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Marshall S, Bacote V and Traxinger RR:
Discovery of a metabolic pathway mediating glucose-induced
desensitization of the glucose transport system. Role of hexosamine
biosynthesis in the induction of insulin resistance. J Biol Chem.
266:4706–4712. 1991.
|
|
3
|
Kreppel LK and Hart GW: Regulation of a
cytosolic and nuclear O-GlcNAc transferase. Role of the
tetratricopeptide repeats. J Biol Chem. 274:32015–32022. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Park SY, Ryu J and Lee W: O-GlcNAc
modification on IRS-1 and Akt2 by PUGNAc inhibits their
phosphorylation and induces insulin resistance in rat primary
adipocytes. Exp Mol Med. 37:220–229. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang X, Ongusaha PP, Miles PD, et al:
Phosphoinositide signalling links O-GlcNAc transferase to insulin
resistance. Nature. 451:964–969. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Buse MG: Hexosamines, insulin resistance,
and the complications of diabetes: current status. Am J Physiol
Endocrinol Metab. 290:E1–E8. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu F, Iqbal K, Grundke-Iqbal I, Hart GW
and Gong CX: O-GlcNAcylation regulates phosphorylation of tau: a
mechanism involved in Alzheimer’s disease. Proc Natl Acad Sci USA.
101:10804–10809. 2004.PubMed/NCBI
|
|
8
|
Slawson C and Hart GW: O-GlcNAc
signalling: implications for cancer cell biology. Nat Rev Cancer.
11:678–684. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pecqueur C, Oliver L, Oizel K, Lalier L
and Vallette FM: Targeting metabolism to induce cell death in
cancer cells and cancer stem cells. Int J Cell Biol.
2013:8059752013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mi W, Gu Y, Han C, et al: O-GlcNAcylation
is a novel regulator of lung and colon cancer malignancy. Biochim
Biophys Acta. 1812:514–519. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gu Y, Mi W, Ge Y, et al: GlcNAcylation
plays an essential role in breast cancer metastasis. Cancer Res.
70:6344–6351. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lynch TP, Ferrer CM, Jackson SR, Shahriari
KS, Vosseller K and Reginato MJ: Critical role of O-linked
β-N-acetylglucosamine transferase in prostate cancer invasion,
angiogenesis, and metastasis. J Biol Chem. 287:11070–11081.
2012.
|
|
14
|
Caldwell SA, Jackson SR, Shahriari KS, et
al: Nutrient sensor O-GlcNAc transferase regulates breast cancer
tumorigenesis through targeting of the oncogenic transcription
factor FoxM1. Oncogene. 29:2831–2842. 2010. View Article : Google Scholar
|
|
15
|
Ma Z, Vocadlo DJ and Vosseller K:
Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive
NF-κB activity in pancreatic cancer cells. J Biol Chem.
288:15121–15130. 2013.PubMed/NCBI
|
|
16
|
Fromowitz FB, Viola MV, Chao S, et al: ras
p21 expression in the progression of breast cancer. Hum Pathol.
18:1268–1275. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Qin JM, Fu XY, Li SJ, et al: Gene and
protein expressions of p28GANK in rat with liver regeneration.
World J Gastroenterol. 9:2523–2527. 2003.PubMed/NCBI
|
|
18
|
Yuzwa SA, Macauley MS, Heinonen JE, et al:
A potent mechanism-inspired O-GlcNAcase inhibitor that blocks
phosphorylation of tau in vivo. Nat Chem Biol. 4:483–490. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gu Y, Zhang J, Mi W, et al: Silencing of
GM3 synthase suppresses lung metastasis of murine breast cancer
cells. Breast Cancer Res. 10:R12008. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu W, Leber B and Andrews DW: Cytoplasmic
O-glycosylation prevents cell surface transport of E-cadherin
during apoptosis. Embo J. 20:5999–6007. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Love DC, Kochan J, Cathey RL, Shin SH and
Hanover JA: Mitochondrial and nucleocytoplasmic targeting of
O-linked GlcNAc transferase. J Cell Sci. 116:647–654. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Itkonen HM, Minner S, Guldvik IJ, et al:
O-GlcNAc transferase integrates metabolic pathways to regulate the
stability of c-MYC in human prostate cancer cells. Cancer Res.
73:5277–5287. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shin SH, Love DC and Hanover JA: Elevated
O-GlcNAc-dependent signaling through inducible mOGT expression
selectively triggers apoptosis. Amino Acids. 40:885–893. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hirohashi S: Inactivation of the
E-cadherin-mediated cell adhesion system in human cancers. Am J
Pathol. 153:333–339. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Park SY, Kim HS, Kim NH, et al: Snail1 is
stabilized by O-GlcNAc modification in hyperglycaemic condition.
EMBO J. 29:3787–3796. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pokutta S and Weis WI: Structure and
mechanism of cadherins and catenins in cell-cell contacts. Annu Rev
Cell Dev Biol. 23:237–261. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shi Y, Tomic J, Wen F, et al: Aberrant
O-GlcNAcylation characterizes chronic lymphocytic leukemia.
Leukemia. 24:1588–1598. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shen DL, Gloster TM, Yuzwa SA and Vocadlo
DJ: Insights into O-linked N-acetylglucosamine ([0-9]O-GlcNAc)
processing and dynamics through kinetic analysis of O-GlcNAc
transferase and O-GlcNAcase activity on protein substrates. J Biol
Chem. 287:15395–15408. 2012.
|
|
29
|
Zhu Q, Zhou L, Yang Z, et al:
O-GlcNAcylation plays a role in tumor recurrence of hepatocellular
carcinoma following liver transplantation. Med Oncol. 29:985–993.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hayward SW, Dahiya R, Cunha GR, Bartek J,
Deshpande N and Narayan P: Establishment and characterization of an
immortalized but non-transformed human prostate epithelial cell
line: BPH-1. In Vitro Cell Dev Biol Anim. 31:14–24. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hayward SW, Wang Y, Cao M, et al:
Malignant transformation in a nontumorigenic human prostatic
epithelial cell line. Cancer Res. 61:8135–8142. 2001.PubMed/NCBI
|
|
32
|
Webber MM, Quader ST, Kleinman HK, et al:
Human cell lines as an in vitro/in vivo model for prostate
carcinogenesis and progression. Prostate. 47:1–13. 2001. View Article : Google Scholar : PubMed/NCBI
|
